Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N A Harris

Showing results (1-10 of 200) with videos related to

Pageof 20
Sort By:
Anaesthesia|May 15, 2008
Unrecognised dural punctures--possible mechanismsN A Harris
Seminars in Respiratory and Critical Care Medicine|February 3, 2015
Clinical management of infections caused by Enterobacteriaceae that express extended-spectrum β-lactamase and AmpC enzymesPatrick N A Harris
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2019
By ZEUS! Can We Use Intravenous Fosfomycin for Complicated Urinary Tract Infections?Patrick N A Harris
British Journal of Anaesthesia|July 13, 2006
Epidural haematomaR G Davis, N A Harris
Nursing History Review : Official Journal of the American Association for the History of Nursing|February 24, 2001
Florence Henderson. The art of open-drop etherN A Harris, J Hunziker-Dean
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2020
Beyond the Core Genome: Tracking Plasmids in Outbreaks of Multidrug-resistant BacteriaPatrick N A Harris, Wailan Alexander M
Lancet (London, England)|November 29, 2013
Melioidosis: refining management of a tropical time bombDale A Fisher, Patrick N A Harris
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2015
Editorial commentary: the new Acinetobacter equation: hypervirulence plus antibiotic resistance equals big troubleDavid L Paterson, Patrick N A Harris
The Lancet. Infectious Diseases|November 26, 2015
Colistin resistance: a major breach in our last line of defenceDavid L Paterson, Patrick N A Harris
International Journal of Antimicrobial Agents|July 25, 2012
Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?P N A Harris, J K Ferguson
Pageof 20

Showing results (1-10 of 200) with videos related to

Sort By:
Pageof 20
Anaesthesia|May 15, 2008
Unrecognised dural punctures--possible mechanismsN A Harris
Seminars in Respiratory and Critical Care Medicine|February 3, 2015
Clinical management of infections caused by Enterobacteriaceae that express extended-spectrum β-lactamase and AmpC enzymesPatrick N A Harris
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2019
By ZEUS! Can We Use Intravenous Fosfomycin for Complicated Urinary Tract Infections?Patrick N A Harris
British Journal of Anaesthesia|July 13, 2006
Epidural haematomaR G Davis, N A Harris
Nursing History Review : Official Journal of the American Association for the History of Nursing|February 24, 2001
Florence Henderson. The art of open-drop etherN A Harris, J Hunziker-Dean
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 8, 2020
Beyond the Core Genome: Tracking Plasmids in Outbreaks of Multidrug-resistant BacteriaPatrick N A Harris, Wailan Alexander M
Lancet (London, England)|November 29, 2013
Melioidosis: refining management of a tropical time bombDale A Fisher, Patrick N A Harris
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2015
Editorial commentary: the new Acinetobacter equation: hypervirulence plus antibiotic resistance equals big troubleDavid L Paterson, Patrick N A Harris
The Lancet. Infectious Diseases|November 26, 2015
Colistin resistance: a major breach in our last line of defenceDavid L Paterson, Patrick N A Harris
International Journal of Antimicrobial Agents|July 25, 2012
Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?P N A Harris, J K Ferguson
Pageof 20